Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?

Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?

Background: Germline pathogenic variants mutations) in the BRCA1 and BRCA2 genes cause an increased risk of breast cancer and ovarian cancer. Mainstream cancer genetic testing (MCG) was introduced for breast cancer patients in our unit in 2013. Non-geneticist clinicians have been trained to offer ge...

Celý popis

Podrobná bibliografie
Hlavní autoři: Quratul Ain, Caroline Richardson, Miriam Mutebi, Angela George, Zoe Kemp, Jennifer E. Rusby
Médium: Článek
Jazyk:English
Vydáno: Elsevier 2023-02-01
Edice:Breast
Témata:
Breast surgery
Risk reduction mastectomy
Risk reduction bilateral mastectomy
Genetic testing
Rapid access gene testing
Familial breast cancer
On-line přístup:http://www.sciencedirect.com/science/article/pii/S096097762200193X

Internet

http://www.sciencedirect.com/science/article/pii/S096097762200193X

Podobné jednotky